Skip to Content

Join the 'Prostate Cancer' group to help and get support from people like you.

Prostate Cancer News

Related terms: Cancer, Prostate, Carcinoma of Prostate

Dad Can Pass on Ovarian Cancer Genes, Too

Posted 1 day 13 hours ago by Drugs.com

FRIDAY, Feb. 16, 2018 – A gene mutation that's passed down from a father is associated with earlier onset of ovarian cancer in daughters and prostate cancer in the father and his sons, a new study suggests. Previous research had shown that sisters of women with ovarian cancer have a higher risk for the disease than their mother, but the reasons for this were unclear. "Our study may explain why ...

Dad Can Pass on Ovarian Cancer Genes, Too

Posted 1 day 13 hours ago by Drugs.com

FRIDAY, Feb. 16, 2018 – A gene mutation that's passed down from a father is associated with earlier onset of ovarian cancer in daughters and prostate cancer in the father and his sons, a new study suggests. Previous research had shown that sisters of women with ovarian cancer have a higher risk for the disease than their mother, but the reasons for this were unclear. "Our study may explain why ...

New Treatment Apalutamide (Erleada) Approved for Prostate Cancer That Resists Hormone Therapy

Posted 3 days ago by Drugs.com

WEDNESDAY, Feb. 14, 2018 – Erleada (apalutamide) has been approved by the U.S. Food and Drug Administration to treat non-spreading prostate cancer that continues to grow despite hormone therapy. Prostate cancer is the second-most-common form of the disease among men in the United States, the National Cancer Institute says. More than 161,000 men were diagnosed in 2017, and nearly 27,000 men were ...

Zytiga (abiraterone acetate) Plus Prednisone Approved for Treatment of Earlier Form of Metastatic Prostate Cancer

Posted 3 days ago by Drugs.com

HORSHAM, PA, Feburary 8, 2018 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Zytiga (abiraterone acetate) in combination with prednisone for the treatment of patients with metastatic high-risk castration-sensitive prostate cancer (CSPC). The approval is based on Phase 3 data from the p ...

FDA Approves Erleada to Help Curb a Tough-to-Treat Prostate Cancer

Posted 3 days ago by Drugs.com

WEDNESDAY, Feb. 14, 2018 – A new drug that can stall the progression of a particularly hard-to-treat form of prostate cancer has been approved for use by U.S. health officials. In a recent study, the drug called Erleada (apalutamide) has shown breakthrough effectiveness in keeping prostate cancer from spreading for two years in men whose disease had not yet traveled to other parts of their body. ...

FDA Approves Erleada (apalutamide) for Non-Metastatic Castration-Resistant Prostate Cancer

Posted 3 days ago by Drugs.com

February 14, 2018 – The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant). This is the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer. “The FDA evaluates a v ...

What Might Make Prostate Cancer's Return More Likely?

Posted 26 Jan 2018 by Drugs.com

FRIDAY, Jan. 26, 2018 – Obesity and other health problems may boost the chances of cancer returning after a man has his prostate removed, a new study finds. "Prostate cancer is the most common cancer in men, and up to 30 percent of patients will develop recurrence after [prostate removal]," said study author Dr. Arash Samiei, of Allegheny Health Network's urology department in Pittsburgh. ...

High Costs Keep Many Cancer Patients From Needed Drugs

Posted 21 Dec 2017 by Drugs.com

THURSDAY, Dec. 21, 2017 – Cancer drugs have become so pricey that U.S. patients often can't afford them, a new study finds. The findings suggest that high out-of-pocket costs may be a barrier to potentially life-saving or life-prolonging treatments, the researchers said, and raise questions about whether patients will be able to take advantage of new cancer treatments. "Imagine leaving your ...

Insurance Ups the Odds of Beating Cancer

Posted 5 Dec 2017 by Drugs.com

TUESDAY, Dec. 5, 2017 – Your chances of surviving cancer may depend on the type of insurance you have. Researchers from the Cancer Prevention Institute of California found significant improvements in survival among cancer patients with private insurance or Medicare, but not among those who have public insurance such as Medicaid, or are uninsured. The investigators analyzed data on more than 1.1 ...

Memo to Doctors: Spit Out the Bad News

Posted 27 Nov 2017 by Drugs.com

MONDAY, Nov. 27, 2017 – Doctors, don't be afraid to deliver bad news. Telling cancer patients the truth about their chances of survival does not harm a physician's relationship with those people. It could even make it better, according to a new study. "We hope this information will reassure clinicians about any negative impacts of these discussions on their relationships with patients," said ...

Could a Common Blood Thinner Lower Cancer Risk?

Posted 7 Nov 2017 by Drugs.com

MONDAY, Nov. 6, 2017 – A pill widely taken to prevent heart attack and stroke may also guard against cancer, new research suggests. Warfarin is an inexpensive blood thinner. It's typically prescribed for patients whose leg arteries are prone to clots and for patients with the abnormal heartbeat called atrial fibrillation. Now, Norwegian investigators say it may also protect against any type of ...

Speed Up the 'Cancer Moonshot,' Doctors Urge

Posted 1 Nov 2017 by Drugs.com

TUESDAY, Oct. 31, 2017 – The Cancer Moonshot Initiative now has a detailed road map designed to cram a decade's worth of medical advancement into half that time. A new report, authored by more than 50 leading U.S. cancer doctors, highlights 13 priority areas for improving the medical response to cancer, along with measurable goals and a specific timeline for meeting each of those objectives. The ...

Health Tip: Recognizing Prostate Cancer

Posted 29 Sep 2017 by Drugs.com

-- Prostate cancer is the most common form of cancer among men. And black men are more likely to get the disease, and twice as likely to die from it, the U.S. Food and Drug Administration says. The slow-growing disease often shows few or no symptoms until it's too late. But if symptoms do emerge, they may include: Difficulty beginning urination. Weak or interrupted flow of urine. Frequent ...

Fewer Uninsured Cancer Patients After Medicaid Expansion

Posted 27 Sep 2017 by Drugs.com

WEDNESDAY, Sept. 27, 2017 – States that expanded Medicaid under the Affordable Care Act halved the number of uninsured cancer patients, a new U.S. study finds. This matters because "uninsured cancer patients are more likely to go without needed care and treatment, such as radiation therapy or surgery to remove tumors," said study lead author Dr. Fumiko Chino. She is a radiation oncology resident ...

Where It's Legal, One-Quarter of Cancer Patients Use Medical Pot

Posted 25 Sep 2017 by Drugs.com

MONDAY, Sept. 25, 2017 – If you legalize medical marijuana, a sizable number of cancer patients will sign up, a new Washington state survey suggests. One-quarter of cancer patients in Washington use marijuana, researchers found. But the study also revealed it can be a challenge to get information about the drug from health care providers. "Cancer patients desire but are not receiving information ...

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

estradiol, Premarin, Estrace, ethinyl estradiol, Lupron Depot, Zoladex, Zytiga, Estradiol Patch, Casodex, view more... Taxotere, Eligard, Cenestin, Xtandi, capecitabine, cyclophosphamide, bicalutamide, flax, esterified estrogens, Enjuvia, degarelix, Trelstar, Menest, Firmagon, Xofigo, Provenge, conjugated estrogens, Trelstar LA, goserelin, Vantas, Sandrena, Progynova, docetaxel, flutamide, leuprolide, abiraterone, Thais, Trelstar Depot, Supprelin LA, Flax Seed Oil, Premarin Intravenous, Delestrogen, nilutamide, sipuleucel-t, Jevtana, radium 223 dichloride, Stilphostrol, Docefrez, Thaissept, Estratab, Systen, Provames, Zoladex 3-Month, Oromone, Primogyn Depot, abarelix, Zumenon, Plenaxis, diethylstilbestrol, estramustine, histrelin, mitoxantrone, triptorelin, cabazitaxel, enzalutamide, apalutamide, Cytadren, Progynova TS, Emcyt, aminoglutethimide, Novantrone, Nilandron, Viadur, Estinyl, Eulexin, Valergen, Erleada